InvestorsHub Logo
Followers 0
Posts 28
Boards Moderated 0
Alias Born 04/07/2016

Re: None

Wednesday, 06/28/2017 3:57:50 PM

Wednesday, June 28, 2017 3:57:50 PM

Post# of 34627
Just curious, does any one have any information on the study scope and design for the NRC beyond what's in this article?


"The Lexaria R&D will include many studies; and their objectives, design, and results will be reported as available. Lexaria’s patent applications name several groups of molecules, all of which will be studied within this budget:

Cannabinoids;
Vitamins;
NSAIDs; and,
Nicotine.

The R&D will include in vitro absorption studies utilizing Lexaria’s technology to examine improvements in absorption across human intestinal tissue."

http://www.lexariaenergy.com/news/lexaria-announces-million-dollar-research-and-development-program/


I work in molecular sciences so I'd be really curious to see the actual designs they have. I know this was only a couple months ago, but just was wondering if any one has seen any kind of update on it. Sounds very interesting/promising. If they can really increase the bioeffeciency of NSAIDs and reduce the deleterious effects on kidneys, thats a potentially $billion market
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News